KIT and gastrointestinal stromal tumor: Chronic c-Kit directed therapies with IM or SM lead to emergence of drug resistant GIST in >50% [~6 months to 3 years] and there is a clear need for a better biologic understanding of the genetic mechanisms of evolution of drug resistance.